175 related articles for article (PubMed ID: 18475269)
1. Response to: Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Morgentaler A
Int J Impot Res; 2008; 20(3):331; author reply 332. PubMed ID: 18475269
[No Abstract] [Full Text] [Related]
2. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel.
Marbury T; Hamill E; Bachand R; Sebree T; Smith T
Biopharm Drug Dispos; 2003 Apr; 24(3):115-20. PubMed ID: 12673669
[TBL] [Abstract][Full Text] [Related]
4. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
5. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
Behre HM; Heinemann L; Morales A; Pexman-Fieth C
Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
[TBL] [Abstract][Full Text] [Related]
6. Transdermal androgens: pharmacology and applicability to hypogonadal elderly men.
Swerdloff RS; Wang C
J Endocrinol Invest; 2005; 28(3 Suppl):112-6. PubMed ID: 16042369
[TBL] [Abstract][Full Text] [Related]
7. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
Swerdloff RS; Wang C
Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
[TBL] [Abstract][Full Text] [Related]
8. Testim 1% testosterone gel for the treatment of male hypogonadism.
Bouloux P
Clin Ther; 2005 Mar; 27(3):286-98. PubMed ID: 15878382
[TBL] [Abstract][Full Text] [Related]
9. Review of Testim gel.
McNicholas T; Ong T
Expert Opin Pharmacother; 2006 Mar; 7(4):477-84. PubMed ID: 16503819
[TBL] [Abstract][Full Text] [Related]
10. Absorption of testosterone gel 1% (Testim) from three different application sites.
Guay AT; Smith TM; Offutt LA
J Sex Med; 2009 Sep; 6(9):2601-10. PubMed ID: 19549089
[TBL] [Abstract][Full Text] [Related]
11. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function.
Blacklock AR
BJU Int; 2003 Sep; 92(4):490. PubMed ID: 12930448
[No Abstract] [Full Text] [Related]
12. Re: Ebert T, Jockenhövel F, Morales A, Shabsigh R. The current status of therapy for symptomatic late onset hypogonadism with transdermal testosterone gel. Eur Urol 2005;47:137-46.
Ponholzer A; Rauchenwald M; Madersbacher S
Eur Urol; 2005 Jul; 48(1):170-1; author reply 171. PubMed ID: 15967269
[No Abstract] [Full Text] [Related]
13. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS).
Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
Aging Male; 2012 Mar; 15(1):14-21. PubMed ID: 22092151
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of testosterone gel in the treatment of male hypogonadism.
Lakshman KM; Basaria S
Clin Interv Aging; 2009; 4():397-412. PubMed ID: 19966909
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Testosterone Topical Solution in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel.
Burns PR; Kim ED; Ruff DD; Seftel AD
Am J Mens Health; 2018 May; 12(3):524-530. PubMed ID: 26438471
[TBL] [Abstract][Full Text] [Related]
16. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function.
McNicholas TA; Dean JD; Mulder H; Carnegie C; Jones NA
BJU Int; 2003 Jan; 91(1):69-74. PubMed ID: 12614254
[TBL] [Abstract][Full Text] [Related]
17. A new testosterone gel (fortesta) for hypogonadism.
Med Lett Drugs Ther; 2011 Apr; 53(1362):29-30. PubMed ID: 21502933
[TBL] [Abstract][Full Text] [Related]
18. Benefits of a new testosterone gel formulation for hypogonadal men.
Kaminetsky JC
Clin Cornerstone; 2005; 7 Suppl 4():S8-12. PubMed ID: 16651207
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy.
Orengo CA; Fullerton L; Kunik ME
J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):20-4. PubMed ID: 15681624
[TBL] [Abstract][Full Text] [Related]
20. Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: evaluation by IIEF score.
Chiang HS; Cho SL; Lin YC; Hwang TI
Urology; 2009 Apr; 73(4):762-6. PubMed ID: 19118875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
